Age and risk of major complications in patients undergoing radical cystectomy for muscle invasive bladder cancer

被引:3
|
作者
Adamczyk, Przemyslaw [1 ]
Kadlubowski, Mateusz [1 ]
Poblocki, Pawel [1 ]
Adamowicz, Jan [2 ]
Ostrowski, Adam [2 ]
Drewa, Tomasz [2 ]
Juszczak, Kajetan [2 ]
机构
[1] Nicolaus Copernicus Hosp, Dept Gen & Oncol Urol, Torun, Poland
[2] Nicolaus Copernicus Univ Torun, Coll Med Bydgoszcz, Clin Gen & Oncol Urol, Torun, Poland
关键词
elderly; Clavien-Dindo scale; laparoscopy; urinary bladder neoplasms; ureterocutaneostomy; POSTOPERATIVE COMPLICATIONS; ELDERLY-PATIENTS; CUTANEOUS URETEROSTOMY; SURGICAL COMPLICATIONS; URINARY-DIVERSION; CONDUIT; CARCINOMA; MORTALITY; DISEASE;
D O I
10.5114/wiitm.2021.103918
中图分类号
R61 [外科手术学];
学科分类号
摘要
Introduction: Radical cystectomy is the treatment of choice for patients with muscle invasive bladder cancer (MIBC), but it may be unsafe in older patients. Aim: In this study, we investigated whether age and selected clinical characteristics were associated with outcomes of radical cystectomy. Material and methods: We enrolled 434 patients with MIBC who underwent radical cystectomy between 2012 and 2016, and we classified them into three age groups: < 65, 66-74, and >_ 75 years. Postoperative complications were classified on the Clavien-Dindo scale. Regression models were used to find predictors of major postoperative complications (Clavien-Dindo score of 3 or more), long hospital stay (> 7 days), blood loss, and operating time. The models included American Society of Anesthesiologists scores, age group, sex, body mass index, Tumor Nodes Metastasis scores, type of urine derivation (ileal conduit or orthotopic bladder vs. ureterocutaneostomy), and operation type (open vs. laparoscopic). Results: In the regression models, age was not a significant predictor of major complications, long hospital stay, or blood loss (p >_ 0.206). Older age was associated with shorter surgery times (p = 0.002). Higher preoperative American Society of Anesthesiologists scores tended to be associated with a greater risk of major complications (odds ratio, 1.47; p = 0.092). Conclusions: Older age was not associated with an increased risk of major complications in patients who undergo radical cystectomy because of MIBC. Therefore, older age alone should not be a contraindication to this operation.
引用
收藏
页码:722 / 727
页数:6
相关论文
共 50 条
  • [41] High Expression of Karyopherin-α2 Defines Poor Prognosis in Non-Muscle-Invasive Bladder Cancer and in Patients with Invasive Bladder Cancer Undergoing Radical Cystectomy
    Jensen, Jorgen Bjerggaard
    Munksgaard, Pia Pinholt
    Sorensen, Christoffer Mork
    Fristrup, Niels
    Birkenkamp-Demtroder, Karin
    Ulhoi, Benedicte Parm
    Jensen, Klaus Moller-Ernst
    Orntoft, Torben F.
    Dyrskjot, Lars
    EUROPEAN UROLOGY, 2011, 59 (05) : 841 - 848
  • [42] Stomal complications in patients undergoing radical cystectomy and ileal conduit urinary diversion for bladder cancer
    Lentz, Aaron
    Sands, Matthew
    Kouba, Erik
    Wallen, Eric M.
    Pruthi, Raj S.
    JOURNAL OF UROLOGY, 2007, 177 (04): : 61 - 61
  • [43] Non-muscle-invasive bladder cancer: The role of radical cystectomy
    Chang, SS
    Cookson, MS
    UROLOGY, 2005, 66 (05) : 917 - 922
  • [44] Radical Cystectomy and the Multidisciplinary Management of Muscle-Invasive Bladder Cancer
    Chedgy, Edmund Charles Paul
    Black, Peter C.
    JAMA ONCOLOGY, 2016, 2 (07) : 855 - 856
  • [45] SEX DIFFERENCES IN MUSCLE-INVASIVE BLADDER CANCER WITH RADICAL CYSTECTOMY
    Liblik, Kiera
    Whitehead, Marlo
    Siemens, Robert
    JOURNAL OF UROLOGY, 2024, 211 (05): : E342 - E343
  • [46] Radical cystectomy in the treatment of non-muscle-invasive bladder cancer
    Safiullin, K. N.
    Karyakin, O. B.
    ONKOUROLOGIYA, 2012, 8 (02): : 40 - 43
  • [47] The role of lymphadenectomy in patients undergoing radical cystectomy for bladder cancer
    Stein J.P.
    Current Oncology Reports, 2007, 9 (3) : 213 - 221
  • [48] Contemporary Use Trends and Survival Outcomes in Patients Undergoing Radical Cystectomy or Bladder-Preservation Therapy for Muscle-Invasive Bladder Cancer
    Cahn, David B.
    Handorf, Elizabeth A.
    Ghiraldi, Eric M.
    Ristau, Benjamin T.
    Geynisman, Daniel M.
    Churilla, Thomas M.
    Horwitz, Eric M.
    Sobczak, Mark L.
    Chen, David Y. T.
    Viterbo, Rosalia
    Greenberg, Richard E.
    Kutikov, Alexander
    Uzzo, Robert G.
    Smaldone, Marc C.
    CANCER, 2017, 123 (22) : 4337 - 4345
  • [49] A phase II study of neoadjuvant erlotinib in patients with muscle-invasive bladder cancer undergoing radical cystectomy: Preliminary results
    Kim, W. Y.
    Grigson, G. I.
    Wallen, E. M.
    Pruthi, R. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [50] CHEMOTHERAPY VS IMMUNOTHERAPY AS NEOADJUVANT THERAPIES IN CISPLATIN-ELIGIBLE PATIENTS UNDERGOING RADICAL CYSTECTOMY FOR MUSCLE INVASIVE BLADDER CANCER
    Nocera, Luigi
    Bandini, Marco
    Basile, Giuseppe
    Moschini, Marco
    Naidu, Shreyas
    Rose, Kyle
    Li, Roger
    Spiess, Philippe
    Necchi, Andrea
    JOURNAL OF UROLOGY, 2023, 209 : E1126 - E1127